Sethera Therapeutics Releases New Paper Introducing Enzymatic Macrocyclization Platform to Upgrade GLP 1 Peptides
SALT LAKE CITY, UT, UNITED STATES, October 14, 2025 /EINPresswire.com/ -- Sethera Therapeutics, a biotechnology company advancing next-generation polymacrocyclic peptide therapeutics, today announced a published study that outlines a new biocatalysis …